35 results about "Kushenin" patented technology

The invention belongs to the technical field of bird repelling of power transmission equipment, and particularly relates to a bird repelling composition applicable to power transmission equipment. The bird repelling composition is prepared from methyl anthranilate, kushenin, szechuan lovage rhizome, rheum officinale, water and auxiliary agents, wherein the auxiliary agents are lauryl sodium sulfate, glycerol and guar gum. The active ingredients are mixed, stirred, heated and dissolved to prepare an oil phase; the water and the auxiliary agents are uniformly mixed and stirred to prepare a water phase; the oil phase is slowly added into the water phase; the mixture is stirred, sheared and emulsified to obtain bird repelling micro-emulsion. When the kushenin, the szechuan lovage rhizome and the rheum officinale are applied to the bird repelling composition, a better flying bird repelling effect can be achieved. Particularly when the bird repelling composition is applied to the power transmission equipment, the transmission equipment can be prevented from being damaged by the bird repelling composition, and the birds can also be effectively prevented from gathering so as to achieve a bird repelling effect. The bird repelling composition has wide adaptation, can be applied to all kinds of power transmission equipment such as high-voltage transmission lines, power transformers and power transmission towers, and has an extremely obvious bird repelling effect.

Disclosed are a pharmaceutical composition comprising kushenin and glycyrrhizic acid or derivatives thereof and the use of the composition in preparing a drug for preventing and treating dermatitis and eczema, wherein the weight ratio of the kushenin or a derivative thereof to the glycyrrhizic acid or a derivative thereof is 10:1-1:10.

The present invention relates to kurarinol dispersing tablet, and belongs to the field of medicine technology. The kurarinol dispersing tablet consists of kurarinol 1-65 wt%, disintegrating agent 2-90 wt%, lubricant and flow assistant 0-20 wt% and adhesive 0-20 wt%. The preparation process of the kurarinol dispersing tablet includes sieving the said components, mixing kurarinol and disintegrating agent, adding adhesive to form soft material, pelletizing, stoving, finishing, mixing with disintegrating agent, lubricant and flow assistant, measuring the content of kurarinol in pellet, weighing, and tablet pressing to obtain kurarinol dispersing tablet. The medicine may be taken after being dispersed in water, chewed or swallowed, and is used clinically in treating chronic viral hepatitis B, leucopenia caused by different reasons and allergic dermatosis. The medicine has the advantages of good dispersing state, high bioavailability, etc.

The invention provides a preparation method of an antitumor pharmaceutical composition. The preparation method is characterized by comprising the following steps: selecting ginseng to prepare ginseng extractum, preparing the ginseng extractum into ginseng extract, preparing astragalus into astragalus extractum, preparing the astragalus extractum into astragalus extract, preparing the ginseng extract, the astragalus extract and kushenin into extractum, preparing the extractum obtained from the ginseng extract, the astragalus extract, and the kushenin into injection, sterilizing at a temperature of 100 DEG C for 30 minutes, carrying out lamp detecting and packaging to prepare a finished product of the antitumor pharmaceutical composition. The preparation method has reasonable flow, the obtained finished product has the advantages of high purity, good quality stability, scientific formula, extract curative effect, capability of significantly improving the KPS score, the clinical symptom score and the QOL score of a patient with advanced malignant tumor, reducing the weight loss, perfecting the living quality of the patient and relieving the clinical symptoms, and low occurrence rate of such adverse reactions as allergy.

The invention relates to a medicinal composition and method for preparation, wherein the medicinal composition is prepared from astragalus root, gen-seng, flavescent sophora root through supersonic extracting, alcohol depositing, water depositing, formulating, loading and freeze-drying. The composition can be used for treating primary liver cancer, lung carcinoma, esophagus cancer, restocarcinoma, malignant lymphoma, gynaecologic carcinoma, leucopenia and chronic hepatitis B.

The invention discloses a biopesticide for killing oncomelania, which comprises the following materials in parts by weight: 35-64 parts of nicotine, 11-19 parts of celastrus angulatus, 10-16 parts of paraquat, 3-7 parts of sapium sebiferum, 15-20 parts of kushenin, 11-14 parts of santonin water aqua, 3-6 parts of fructus amomi, 10-12 parts of juglone, 25-36 parts of broad beans, 45-50 parts of ethanol, 5-11 parts of hirsutella thompsonii fisher powder and 35-40 parts of sanguinarine. The biopesticide disclosed by the invention has a good killing effect, and is quite obvious in function of killing oncomelania under a low concentration; and the biopesticide is low in toxicity to human, animals, aquatic plants and other aquatic animals, and is capable of relieving pollution to soil and water quality. The biopesticide disclosed by the invention is simple in formula, and easy and simple in preparation method.

The invention relates to a raw material composition and preparation method of a sustained-release drought-resistant water-retention nutrient. The drought-resistant water-retention nutrient provided by the invention is prepared from the following raw materials in parts by weight: 550-700 parts of HA35% ammonium phytate, 80-200 parts of N64% coated urea, 60-150 parts of P14 phosphate fertilizer, 60-150 parts of N17 and P44 ammonium phosphate, 20-35 parts of chitin, 3-30 parts of 80-mesh kushenin and 20-50 parts of glauconite. The sustained-release drought-resistant water-retention nutrient prepared by the preparation method provided by the invention has the characteristics of synchronous plant absorption and sustained release, high water absorption capability, good stress resistance and water retention properties, entire nutrients, rich bioactive substances and soil activation, can improve leaf photosynthesis, prevent bacteria infection and alleviate drought-induced plant physiological damage, has significant effects in greenness, environment friendliness and quality and efficiency improvement, is especially suitable for production of food economical crops, and has persistency and controllability on the drought resistance and nutrient supply.

The invention relates to kushenin (oxymatrine and matrine) and glycyrrhizic acid or their pharmaceutically acceptable forms or derivatives and a kit containing the compositions, also relates to matrine glycyrrhizate and kushenin glycyrrhizate, and discloses an application of the compositions in preparation of drugs for preventing and treating sterile pustular dermatosis (comprising impetigo herpetiformis, acrodermatitis continua, palmoplantar pustulosis, subcorneal lpustular dermatosis, and eosinophilic pustular folliculitis).

The invention provides a medicinal composition which comprises kurarinone or its derivatives and isoglycyrrhizinic acid or its derivatives. The invention also provides the use of the pharmaceutical composition in treating acute and chronic hepatitis and related diseases. the invention also provides various dosage forms of the pharmaceutical composition.

The invention provides an anti-virus or / and anti-tumor drug and a preparation method thereof and an application of fenugreek biflavone glycosides for preparing anti-virus or / and anti-tumor drugs. The invention provides the application of the chemical component fenugreek biflavone glycosides in fenugreek seeds as drugs for the first time, and uses the fenugreek biflavone glycosides for preparing anti-virus drugs and anti-tumor drugs for the first time. In vivo and in vitro experiment research shows that fenugreek biflavone glycoside tablets or fenugreek biflavone glycoside capsules of the invention have obvious effect on resisting influenza viruses, and the anti-influenza drug effect of the fenugreek biflavone glycoside tablets or fenugreek biflavone glycoside capsules of the invention is superior to the anti-influenza drug effect of the existing Western medicine ribavirin tablets. The anti-HBV effect of the fenugreek biflavone glycoside tablets or fenugreek biflavone glycoside capsules is superior to the anti-HBV effect of kurarinone capsules, and the anti-HIV effect of the fenugreek biflavone glycoside tablets or fenugreek biflavone glycoside capsules is superior to the anti-HIV effect of zidovudine tablets. The fenugreek biflavone glycoside tablets or fenugreek biflavone glycoside capsules have obvious effect on resisting proliferation of liver cancer, gastric cancer, intestinal cancer, lung cancer and cervical cancer cells, and the anti-tumor effect of the fenugreek biflavone glycoside tablets or fenugreek biflavone glycoside capsules is superior to the anti-tumor effect of the existing chemical component preparation hydroxycamptothecine injection.

The invention relates to kushenin (oxymatrine, matrine and isomatrine) and glycyrrhizic acid or their pharmaceutically acceptable forms or derivatives and a kit containing the compositions, and also relates to matrine glycyrrhizate and kushenin glycyrrhizate. The invention discloses an application of the compositions in preparation of drugs for preventing and treating neuropsychic disturbance dermatosis (pruritus, lichen simplex chronicus, prurigo, nodular prurigo, prurigo pigmentosa and lichenoid dermatitis).

Disclosed are a pharmaceutical composition comprising kushenin and glycyrrhizic acid or derivatives thereof and the use of the composition in preparing a drug for preventing and treating psoriasis, wherein the weight ratio of the kushenin or a derivative thereof to the glycyrrhizic acid or a derivative thereof is 10:1-1:10.